| |
| |
|
| Insider
Information: |
Macdonald Guy |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
42,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$49,280 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,000 |
|
|
| Total
Value |
$49,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 9.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idenix Pharmaceuticals Inc |
IDIX |
Executive VP, Operations |
2004-07-27 |
10,000 |
2004-07-27 |
0 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2020-07-28 |
0 |
2014-02-10 |
0 |
Premium* |
|
|
Scynexis Inc |
SCYX |
|
2023-06-15 |
32,000 |
2016-06-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCYX |
Scynexis Inc |
|
• • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
32,000 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
22,000 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2020-12-21 |
4 |
B |
$6.25 |
$50,000 |
D/D |
8,000 |
12,000 |
2.39 |
% |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2020-07-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,703) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2019-12-06 |
4 |
S |
$2.25 |
$12,903 |
D/D |
(5,735) |
250 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2019-12-05 |
4 |
S |
$2.34 |
$4,377 |
D/D |
(1,870) |
5,985 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2018-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,332 |
134,396 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,058 |
131,064 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2017-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,566 |
129,006 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,101 |
127,440 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2017-02-09 |
4 |
OE |
$2.90 |
$88,096 |
D/D |
30,378 |
124,339 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2016-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,204 |
93,961 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2016-06-24 |
4 |
B |
$2.39 |
$95,600 |
D/D |
40,000 |
40,000 |
2.39 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2016-05-16 |
4 |
OE |
$0.87 |
$22,031 |
D/D |
25,323 |
90,757 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2016-01-06 |
4 |
OE |
$0.87 |
$10,440 |
D/D |
12,000 |
64,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-09-01 |
4 |
AS |
$41.57 |
$415,700 |
D/D |
(10,000) |
52,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-09-01 |
4 |
OE |
$7.94 |
$79,400 |
D/D |
10,000 |
62,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-08-24 |
4 |
OE |
$0.87 |
$10,440 |
D/D |
12,000 |
52,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-08-06 |
4 |
AS |
$43.65 |
$1,309,500 |
D/D |
(30,000) |
40,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-08-03 |
4 |
OE |
$7.94 |
$79,400 |
D/D |
10,000 |
80,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-08-03 |
4 |
AS |
$47.45 |
$474,500 |
D/D |
(10,000) |
70,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-07-20 |
4 |
AS |
$50.72 |
$760,800 |
D/D |
(15,000) |
70,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-07-01 |
4 |
AS |
$47.92 |
$479,200 |
D/D |
(10,000) |
85,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-07-01 |
4 |
OE |
$7.94 |
$79,400 |
D/D |
10,000 |
95,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-06-01 |
4 |
AS |
$41.86 |
$673,832 |
D/D |
(16,087) |
85,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
